Safety, Tolerability, and Pharmacokinetics Study of Elpipodect (MK-8189) in Participants With Schizophrenia and Healthy Participants (MK-8189-011)
Clinical trial NCT04506905 · COMPLETED
Trial details
- NCT number
- NCT04506905
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-28
- Primary completion
- 2022-03-22
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.